Verition Fund Management’s Akcea Therapeutics Inc AKCA Stock Holding History

Verition Fund Management’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-11,352	Closed	-$206K	–	1544
2020 Q3	$206K	Buy	+11,352	New	+$161K	﹤0.01%	928

Verition Fund Management's AKCA Position: Q4 2020 in Review

Verition Fund Management sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 11,352 shares — an estimated $206K sold.

Verition Fund Management first reported a position in AKCA in Q3 2020 and held it in 1 quarter. The position peaked at $206K in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

Verition Fund Management reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
Verition Fund Management sold 11,352 Akcea Therapeutics Inc shares in Q4 2020, an estimated $206K.
Verition Fund Management first reported a position in Akcea Therapeutics Inc in Q3 2020 and held it in 1 quarter.
Verition Fund Management's Akcea Therapeutics Inc position peaked at $206K in Q3 2020.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Verition Fund Management's 13F filing for Q4 2020, filed 16 Feb 2021.